Jiang Xiaomeng Talks about New Requirements for Enterprise Development after the 19th National Congress
Release time:
2020-08-14
Adhering to the Party's Leadership, Adhering to Reform and Innovation
Adhering to Integration and Optimization, Expanding Growth Space
Jiang Xiaomeng Talking about New Requirements for Enterprise Development after the 19th National Congress
News The 19th National Congress of the Communist Party of China was held in Beijing from 10 18 to 24 . How to learn and practice the spirit of the 19th National Congress, so that enterprises in the new era of socialism with Chinese characteristics to get better development? 11 8 held in Zhejiang Province Building Materials Industry Association "learning the spirit of the 19th National Congress, practice the new era journey" learning seminar, group company party secretary, chairman, Zhejiang Building Materials Industry Association President Jiang Xiaomeng targeted four points of view.
Jiang Xiaomeng, after interpreting the main points of the 19 major reports and recent relevant documents, pointed out that the 19 major reports of the Party are of epoch-making and milestone significance. General Secretary Xi Jinping's report is a political declaration and program of action for socialism with Chinese characteristics to enter a new era, open a new journey and continue to write a new chapter, it is also a scientific guide and action guide for enterprise innovation and development, innovation and achievement of new goals. If enterprises want to keep up with the pace of the new era and achieve further development, they must focus on four aspects.
We must uphold and strengthen the party's overall leadership over enterprises. In-depth study, publicity and implementation of the spirit of the 19th National Congress of the Communist Party of China is the primary political task at present and in the future. It is necessary to deeply understand the new major judgments, new theoretical generalizations, and new strategic arrangements, and earnestly understand and implement them. The 19th National Congress of the Communist Party of China established Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era as the guiding ideology that our party must adhere to for a long time and wrote it into the party constitution. It is the biggest highlight and the most important historical contribution. Enterprises must conscientiously study and implement the spirit of the 19th National Congress of the Communist Party of China, especially in-depth study and understanding of the rich connotations of Xi Jinping's thoughts on socialism with Chinese characteristics in the new era, resolutely maintain the authority and centralized leadership of the Party Central Committee with Comrade Xi Jinping at the core, and effectively enhance political awareness and core awareness, Awareness of the overall situation, and awareness of alignment.
We should adhere to reform and innovation and effectively enhance the endogenous power of enterprises. The report of the 19th National Congress of the Communist Party of China pointed out that my country's economy has shifted from a stage of high-speed growth to a stage of high-quality development. It is in a critical period of transforming development mode, optimizing economic structure, and transforming growth momentum. It is necessary to implement new development concepts and build a modern economic system. To build a modern economic system, we must focus on the real economy, speed up the construction of a manufacturing power, speed up the development of advanced manufacturing, support the optimization of traditional industries, speed up the development of modern service industry, build and promote China's industry to the middle and high end of the global value chain, and cultivate a number of world advanced manufacturing clusters. The report of the 19th National Congress of the Communist Party of China put forward clear requirements for accelerating the construction of an innovative country, scientific and technological innovation, scientific and technological system reform, and innovation system construction. In recent years, the rapid development of many enterprises is mainly due to the four major innovations of science and technology, mechanism, business model and management. In the future, we should further vigorously build innovative enterprises and further release the vitality of development; cultivate new momentum of enterprise development through business model innovation, vigorously develop new models such as "smart industry", and further promote the deep integration of enterprises with the Internet and big data, actively explore new models in the fields of innovation leadership, green and low-carbon, sharing economy, and modern supply chain; solve efficiency and cost problems through management innovation to ensure the quality of business operations; promote technological innovation and occupy the commanding heights of future development by giving full play to technological advantages; It is also necessary to cultivate an innovative culture and strengthen the construction of innovative talents.
to adhere to the integration and optimization, improve enterprise efficiency. When talking about the implementation of the new development concept and the construction of a modern economic system, the report of the 19th CPC National Congress pointed out that China's economy is in a critical period of changing the mode of development, optimizing the economic structure, and changing the driving force of growth, and it is necessary to take supply-side structural reform as the main line. adhere to quality first, benefit first. Enterprises should further optimize the layout, promote the integration and optimization of industries and enterprises, make every effort to promote the elimination of production capacity, promote products to the high end, expand effective and high-end supply, and strive to be the vanguard of promoting the structural reform of the industry and the leader of promoting the transformation and upgrading of the industry.
should actively participate in the construction of "the belt and road initiative" and expand the enterprise market and growth space. The report of the 19th CPC National Congress pointed out that at present, China is getting closer to the center of the world stage, and we should continue to adhere to the basic national policy of opening up to the outside world, focus on the construction of "Belt and Road Initiative", and promote the formation of a new pattern of all-round opening up. The construction of "the belt and road initiative" provides great opportunities for Chinese enterprises to expand the international market and growth space. Enterprises must seize this historical opportunity, be the advance team of the "Belt and Road" construction, and strive to become a dominant enterprise in the allocation of resources, a leading enterprise in the development of the global industry, and a voice in the development of the global industry. And influential enterprises have made fundamental contributions to the creation of the "Belt and Road" "co-consultation, co-construction, sharing, and openness" pattern. (Zhou Hengbin Fu Yiwu)
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31